RIPRETINIB (has an active metabolite) | RIPRETINIB | ATC L01EX19
ANTINEOPLASTIC KIT PROTO-ONCOGENE RECEPTOR TYROSINE KINASE INHIBITOR PLATELET DERIVED GROWTH FACTOR RECEPTOR A (PDGFRA) INHIBITOR TREATMENT OF ADVANCED GASTROINTESTINAL STROMAL TUMOR (GIST) INHIBITS PDGFRB, TIE2, VEGFR2, AND BRAF | ORAL | Cmax 1.49 MICROMOLAR Tmax 4 HOUR VD 307 LITER PPB 99.8 PERCENT Cl 15.3 LITER / HOUR HT 14.8 HOUR SOLUBILITY PRACTICALLY INSOLUBLE IN WATER | PROTO-ONCOGENE RECEPTOR TYROSINE KINASE (KIT) | Unknown - more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |